Martha sees Delta impact lifting soon, talks vaccines, Intersect ENT and patient safety

Geoff Martha, chairman and CEO of Medtronic, updates us on Medtronic’s first-quarter performance. Martha reports the Delta variant has had an impact on revenue, but Medtronic forecasts a return to normal soon. This episode also discusses the Intersect ENT acquisition, the source of future growth and the company’s new metrics on patient safety.